Fabio Salamanca-Buentello

Fabio Salamanca-Buentello is a Mexican physician focused on the development and implementation of emergent technologies for the benefit of the developing world. After graduating from the Faculty of Medicine of the National University of Mexico (UNAM), he worked in the molecular genetics of human cancer and in the molecular basis of memory. He holds a MSc in Bioethics from the University of Toronto Joint Centre for Bioethics and is currently pursuing his PhD through the University of Toronto Institute of Medical Science. He is currently involved in the design of technology roadmaps that will enable the discoveries and inventions resulting from the Bill and Melinda Gates Foundation Grand Challenges in Global Health projects to become actual products that can be applied in the specific contexts of developing countries. Fabio coordinated a project that identified and ranked the ten applications of nanotechnology most likely to benefit the developing world. This project was very successful and had a significant impact worldwide in drawing attention to the potential of nanotechnology to improve the quality of life of the more than 5 billion people living in less industrialized countries. Fabio has also been involved in harnessing genomic medicine to advance global health. He was the Coordinator of the Executive Course on Genomics and Public Health Policy for Latin America and the Caribbean, which was co-organized by the University of Toronto Joint Centre for Bioethics, the Pan American Health Organization, and the United Nations University Program in Biotechnology for Latin America and the Caribbean. Fabio is a member of the Genomics and Nanotechnology Working Group of the United Nations Millennium Project Task Force on Science, Technology and Innovation, and member of the Advisory Board of The Nanoethics Group and of the Editorial Board of the journal NanoEthics: Ethics for Technologies that converge at the nanoscale. He is also a member of the UNESCO Expert Committee on Nanoethics.